Search results

We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal

Our forward view highlights the areas we will prioritise in the coming year.

Past technology appraisal appeals and decisions

Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country

Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.

Our quality standards set out priority areas for quality improvement in health, public health and social care.

A timeline showing where in the NICE evaluation process companies will be charged.

A step-by-step summary about how we develop our technology appraisal guidance.

NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.

Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.

Ask an expert from NICE International, part of the UK's National Institute for Health and Care Excellence, to speak at a healthcare event in your country

The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.

Tools for building or evaluating a medtech evidence base with NICE

Managed access allows people to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.